Macquarie Stem Cells has provided this information to educate the public based on peer reviewed, published scientific and medical documents. Our intent is to provide access to a clinical trial.
Dr. Bright of Macquarie Stem Cells in conjunction with Cell-Innovations has recently pioneered the work into the treatment of chronic migraines. Sufferers of chronic migraines typically have more than 15 migraines or tension-type headaches per month. This study has shown the potency of this treatment on those people who are at the extreme end of the disease.
Of the 4 chronic migraine patients treated 3 out of the 4 patients obtained long term relief from migraines for up to 12 – 18 months with a decrease of more than 95% of migraines and tension-type headaches during the study. It is still unknown how long the effects of the treatment will be for or whether further treatments will be required.
Below is a copy of the Abstract published and complete article.
This case series is the first to provide evidence of the efficacy of biological interventions in the treatment of migraine and tension-type headache. The treatment of this disease by utilising bioloigcal interventions adds a new dimension to its clinical applicability and suggests a relatively simple treatment that may help address the symptoms of the disease. Given what is known about the components of the our bodies biological approach for repairs, the information presented in this case series may also further our knowledge of the etiology and pathophysiology of migraine and tension-type headaches. This treatment is simple, looks to be extremely effective and has been life changing for these patients. (Bright R., et al, 2014)
Patient applications are open – for further information to become an applicant you will need to read the suitability criteria presented in the trial link below. (click on the picture)
Study procedure and care will be provided at no cost. For more information about the potential benefits and risks of the study please contact the trial coordinator at email@example.com
This study has been approved by the Northern Sydney Local Health District Human Research Ethics Committee, reference number: HREC/15/HAWKE/279.
The trial has been registered with the Australia and New Zealand Clinical Trials Registry (trial ID ACTRN12615001260516)
If you match the criteria, please send an email directly to firstname.lastname@example.org to participate in the trial.